Patient Association: Europa Donna Lyon (France): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forpatients</span> <span style="display:none">francecountry</span> | |||
Go back to [[France]] page | Go back to [[France]] page | ||
'''Primary purpose:''' To bring together women affected by breast cancer, their loved ones, and healthcare professionals, providing support, communication, information, and an exchange platform to share experiences and promote awareness of their actions and initiatives. | '''Primary purpose:''' To bring together women affected by breast cancer, their loved ones, and healthcare professionals, providing support, communication, information, and an exchange platform to share experiences and promote awareness of their actions and | ||
initiatives. | |||
''' | '''Cancer areas of interest:''' [[hasCancerType:: C50: Breast cancer]]. [https://www.europadonna.fr/delegations/europa-donna-auvergne-rhone-alpes-lyon/ Click here to learn more]. | ||
'''Access to information''': [https://www.europadonna.fr/delegations/europa-donna-auvergne-rhone-alpes-lyon/ Click here to access]. | |||
<span style="display:none">Lobular</span> | |||
<span style="display:none">Breast</span> | |||
<span style="display:none">Nipple</span> | |||
<span style="display:none">Areola</span> | |||
<span style="display:none">Ductal</span> | |||
<span style="display:none">hasCancerType:: C50: Breast cancer</span> | |||
<span style="display:none">isPatientAssociation</span> | |||
Latest revision as of 19:26, 3 December 2025
Go back to France page
Primary purpose: To bring together women affected by breast cancer, their loved ones, and healthcare professionals, providing support, communication, information, and an exchange platform to share experiences and promote awareness of their actions and initiatives.
Cancer areas of interest: C50: Breast cancer. Click here to learn more.
Access to information: Click here to access.
